Replimune Group, Inc.

REPL · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income-$247-$216-$174-$118
Dep. & Amort.$4$3$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$35$34$28$24
Change in WC$24$5$15$7
Other Non-Cash-$8-$12$0$2
Operating Cash Flow-$192-$185-$128-$82
Investing Activities
PP&E Inv.-$7-$6-$2-$2
Net Acquisitions$0$0$0-$0
Inv. Purchases-$404-$490-$583-$256
Inv. Sales/Matur.$386$592$443$256
Other Inv. Act.$0$0-$0$0
Investing Cash Flow-$24$97-$143-$2
Financing Activities
Debt Repay.-$1$15$28-$0
Stock Issued$156$2$187$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$97$0$96$0
Financing Cash Flow$252$16$311$7
Forex Effect$0-$0-$0$1
Net Chg. in Cash$37-$72$41-$77
Supplemental Information
Beg. Cash$76$148$108$184
End Cash$113$76$148$108
Free Cash Flow-$199-$191-$130-$85
Replimune Group, Inc. (REPL) Financial Statements & Key Stats | AlphaPilot